Влияние недавних изменений в GVP ЕАЭС
January 21, 2025
QPPV in the CIS: Challenges and Opportunities
The fast-growing pharmaceutical market in the CIS countries presents a lot of opportunities for pharmaceutical manufacturers. However, it also comes with challenges.
For example, the legislative requirements for Pharmacovigilance (PV) and the appointment of QPPV or LPPV (Local Person for Pharmacovigilance) are different in the CIS countries.
The QPPV or LPPV must be appropriately qualified in PV including according to local legislation, in most cases a resident of the country with a deep understanding of local legislation and fluent command of the local language(s).
Moreover, in some CIS countries, there is no clear Pharmacovigilance legislation and requirements for QPPV or LPPV, as well as division of responsibilities between the LPPV, MAH, and manufacturer, leading to misunderstandings and challenges in the regulatory process.
Inpharmatis is your guide to Pharmacovigilance in the CIS countries:
- Covers all CIS countries, eliminating the need to seek and manage partners in each country separately
- Acts as a local legal entity, where it is necessary, maintaining representative offices or branches
- Has local full-time, highly qualified, experienced, multilingual employees in CIS countries
- Provides personalized solutions, making your presence in the CIS markets straightforward, compliant, and efficient.
Request a consultation now at info@inpharmatis.com.
Explore full pharmacovigilance services on Inpharmatis website - www.inpharmatis.com.


Impact of Recent Changes in EAEU GVP
January 21, 2025
Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024
Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024
Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024